177 filings
Page 2 of 9
SC 13G/A
MDNAF
Medicenna Therapeutics Corp.
7 Feb 24
Medicenna Therapeutics / HIRSCHMAN ORIN ownership change
6:55pm
6-K
MDNAF
Medicenna Therapeutics Corp.
24 Jan 24
Notice of Change of Auditor
4:00pm
6-K
MDNAF
Medicenna Therapeutics Corp.
12 Jan 24
Medicenna Announces Appointment of New Auditor
7:15pm
6-K
MDNAF
Medicenna Therapeutics Corp.
9 Jan 24
Medicenna Commences Enrollment in the ABILITY-1 Study Combining MDNA11 with Pembrolizumab
10:33am
6-K
MDNAF
Medicenna Therapeutics Corp.
5 Jan 24
Notice of Change of Auditor
9:06am
6-K
MDNAF
Medicenna Therapeutics Corp.
22 Dec 23
Current report (foreign)
2:13pm
6-K
MDNAF
Medicenna Therapeutics Corp.
21 Dec 23
Medicenna Announces Trading on the OTCQB Under the Symbol MDNAF
7:31pm
6-K
MDNAF
Medicenna Therapeutics Corp.
21 Nov 23
Current report (foreign)
10:39am
25-NSE
MDNAF
Medicenna Therapeutics Corp.
20 Nov 23
Exchange delisting
8:49am
6-K
MDNAF
Medicenna Therapeutics Corp.
14 Nov 23
Interim condensed consolidated financial statements of
12:00am
6-K
MDNAF
Medicenna Therapeutics Corp.
8 Nov 23
Medicenna Announces Nasdaq Delisting and Cutback of Management Team
10:29am
6-K
MDNAF
Medicenna Therapeutics Corp.
25 Oct 23
Current report (foreign)
3:51pm
6-K
MDNAF
Medicenna Therapeutics Corp.
24 Oct 23
Current report (foreign)
7:18am
6-K
MDNAF
Medicenna Therapeutics Corp.
10 Oct 23
Medicenna Therapeutics Appoints Humphrey Gardner, M.D., as Chief Medical Officer
8:57am
6-K
MDNAF
Medicenna Therapeutics Corp.
3 Oct 23
Medicenna Presents Preclinical MDNA223 BiSKIT Data at the AACR Special Conference on Tumor Immunology and Immunotherapy
5:00pm
6-K
MDNAF
Medicenna Therapeutics Corp.
28 Sep 23
Medicenna Announces Results of Annual and Special Meeting of Shareholders
5:00pm
6-K
MDNAF
Medicenna Therapeutics Corp.
28 Sep 23
Current report (foreign)
10:59am
6-K
MDNAF
Medicenna Therapeutics Corp.
6 Sep 23
Medicenna to Participate at The H.C. Wainwright 25th Annual Global Investment Conference
7:13am
6-K
MDNAF
Medicenna Therapeutics Corp.
28 Aug 23
Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer
4:50pm
6-K
MDNAF
Medicenna Therapeutics Corp.
28 Aug 23
Current report (foreign)
4:49pm